2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant that elicits a wide range of toxic effects on the developing organism. In this study, we demonstrate that the fetal and neonatal rat lung contains a responsive Ahrsignaling pathway which upon activation by a gestational exposure to TCDD, leads to altered lung development. Pregnant Holtzman rats received a single oral dose of TCDD (1.5 or 6 mg/ kg) on gestation day (GD) 10 or a vehicle control with fetal and neonatal analysis occurring on GD20 or postnatal day (PND) 7. Components of the aryl hydrocarbon receptor (Ahr) signaling pathway (Ahr and Arnt) were identified in the fetal and neonatal lung tissue through the use of real-time PCR and immunohistochemical staining at both time points. Additionally, the Ahrsignaling pathway was found to be responsive to the gestational TCDD exposure as demonstrated by the induction of Cyp1a1, Cyp1b1, and Ahrr in both fetal and neonatal lung tissue. Morphometric analysis of GD20 and PND7 fixed lung tissue sections revealed that treated pups had significant decreases in total airspace area while having significantly wider tissue septa separating the airspaces as well as a decreased dry lung weight to body weight ratio when compared with controls; indicative of lung immaturity and hypoplasia. Finally, the assessment of respiratory mechanics on PND7 pups revealed functionally different pressurevolume curves in TCDD-exposed pups when compared with control animals. Together, these data identify a responsive Ahrsignaling pathway in the developing lung which may be related to the pulmonary immaturity and hypoplasia induced by TCDD and demonstrates that gestational exposure to TCDD alters lung development in such a manner that changes in lung morphology are associated with functional differences in respiratory mechanics.
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The development of the respiratory system, in man or mouse, is an exceedingly complex process that can be adversely influenced by toxins and toxicants. Starting from a small protruding bud of endoderm, a highly organized organ system develops. In humans, the end result is a lung that is innervated, vascularized, and organized into a complex airway branching system containing over 25,000 distinct branching terminations giving rise to an estimated 300-400 million alveoli (Ochs et al., 2004) and consisting of over 40 different cell types (Sorokin, 1970) .
Lung development is driven by two biological forces. First are the intrinsic forces of the morphoregulatory molecules (transcription factors, signaling molecules and extracellular matrix proteins) (Cardoso, 2000 (Cardoso, , 2001 Cardoso and Lu, 2006; Copland and Post, 2004; Costa et al., 2001; Demayo et al., 2002; Desai and Cardoso, 2002; Hilfer, 1996; Jobe and Ikegami, 2000; Kotecha, 2000; Mendelson, 2000; Minoo, 2000; Warburton et al., 2003) . Second are the extrinsic forces of fetal lung fluid and fetal breathing that help define the three-dimensional airspace. Modulating any of these forces can adversely affect the developing lung. For example, numerous research models that modulate various transcription factors and regulatory molecules involved in lung development have resulted in an altered lung phenotype (Cardoso, 1995; Cardoso and Lu, 2006) . Everyday, humans, animals and wildlife are exposed to a myriad of environmental contaminants. Developing organisms are a population uniquely sensitive to these exposures due to the wide variety of changes in cell differentiation and growth that are occurring. Some of the most toxic compounds to a developing conceptus are those that persist in the environment, bioaccumulate, and biomagnify in the food chain. 2, 3, 7, , the most widely studied member of the persistent organic pollutants, exhibits these properties. TCDD is the highest affinity ligand for the aryl hydrocarbon receptor (Ahr), a cytosolic ligand-activated transcription factor and member of the basic helix-loop-helix (bHLH), Per-Arnt-Sim (PAS) family of proteins. Upon ligand binding, Ahr translocates into the nucleus and dimerizes with Ahr nuclear translocator (Arnt) and subsequently binds to dioxin-response elements (DREs) located in the 5# region of responsive genes resulting in a wide variety of changes in gene expression (Ovando et al., 2006; Vezina et al., 2004) .
We have previously reported that the developing lung is a target organ for the toxic effects of TCDD (Kransler et al., 2007b) . Timed pregnant Holtzman rats exposed to TCDD (1.5 or 6 lg/kg) on gestation day (GD) 10 with fetal or neonatal analysis occurring on GD20 or PND7 exhibit decreased fetal and neonatal lung weights and normalized lung-to-body weight ratios (Kransler et al., 2007b) . However, there have been no prior studies that have examined the role of the Ahr-signaling pathway or the toxic effects of TCDD on the developing lung. Based on our previous observations, we hypothesized that the developing lung contains a responsive Ahr-signaling pathway that upon activation leads to changes in gene expression that adversely affects lung development. Timed pregnant Holtzman rats were exposed to TCDD (1.5 or 6 lg/kg) on GD 10 with fetal or neonatal analysis occurring on GD20 or postnatal day (PND) 7. Significant increases in perinatal mortality were observed in dams exposed to TCDD. Offspring that were viable from the TCDD-exposed dams exhibited pulmonary hypoplasia. Real-time PCR was used to quantify changes in gene expression while immunohistochemistry (IHC) was used to localize proteins of the Ahr-signaling pathway in the developing lung. Imaged histological sections of fixed lung tissue were subjected to automated morphometric assessment for structural characterization with significant differences between the amount of airspace area and tissue area detected between control and treated animals on both GD20 and PND7. Finally, static pressure-volume (PV) curves were generated on PND7 to assess functional respiratory mechanics. Together, these data identify a responsive Ahr-signaling pathway in the developing lung which may be related to the pulmonary immaturity and hypoplasia induced by TCDD and demonstrate that gestational exposure to TCDD alters lung development in such a manner that changes in lung morphology are associated with functional differences in respiratory mechanics.
MATERIALS AND METHODS
Chemicals. TCDD (purity > 99%) was a gift from Dow Chemical Co. (Midland, MI) and dissolved in 1,4-dioxane (J.T. Baker Chemical Co., Phillipsburg, NJ). Concentrations of TCDD in the dosing solutions were validated via gas chromatography with electron capture detection (GC-ECD), data not shown. All other chemicals and reagents used were obtained from commercial sources and were of the highest quality available.
Animals. Timed pregnant Holtzman rats (HsdHot:Holtzman SD) verified as specific pathogen free, were obtained from Harlan Sprague Dawley, Inc. (Indianapolis, IN). All animals were housed individually and allowed access to food (Harlan Teklad 2016 rodent chow) and water ad libitum. Animal cages were maintained under controlled temperature (25°C) and light conditions (12/12 h light-dark). Animals were randomly assigned to control or treated groups. All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee at the University at Buffalo.
Experimental design. Pregnant rats, 22-day gestation period, received a single oral dose of either a corn oil vehicle control or TCDD in corn oil (0, 1.5, or 6.0 lg/kg) via gastric gavage on GD10 and were sacrificed on GD20 or PND7. The doses of TCDD were chosen to ensure that the low dose would not be associated with changes in neonatal body weight and were based on previous studies (Kransler et al., 2007a (Kransler et al., , b, 2008 . Gestation day 10 corresponds to Carnegie Stage 9 of development, the approximate start of organogenesis (Hill, 2007) . On the day of sacrifice, animals were anesthetized with sodium pentobarbital (100 mg/kg, ip) and euthanized via decapitation. All animals were monitored daily for signs of overt toxicity resultant from TCDD exposure.
Viability assessment. Maternal toxicity was evaluated by examining changes in organ and body weight during the study. On GD20 and PND7, the uterus was dissected to determine the number and uterine position of implantation sites in each dam for comparison to the number of viable neonates. At the time of tissue collection, the gravid uterus was examined with the number and uterine position of implantation sites, viable fetuses, resorptions, and late fetal deaths recorded. Fetuses were considered viable if after being removed from the uterus, palpation resulted in spontaneous movement. Viable fetuses were measured for body weight, crown-to-rump length, liver, and lung weight. Nonviable fetuses were classified into one of two categories, embryo resorption or late fetal death (LFD). An embryo resorption was recorded when a nondistinct mass was visible at an implantation site. A fetus that failed to meet the criteria of being viable and in the initial stages of resorption was classified as a LFD. In all cases, the litter was considered the experimental unit for analysis.
Lung collection. Immediately after dissection, whole lungs, less the trachea, were weighed with the value recorded as the wet lung weight. If not selected for RNA analysis or histological examination, lungs were thoroughly dehydrated using a Savant Speed Vac Plus evaporative dehydrator for approximately 20 h (Holbrook, NY) and weighed with the value recorded as the dry lung weight.
RNA isolation. Freshly dissected fetal or neonatal lungs were stored in microfuge tubes containing RNAlater (Ambion, Inc., Austin, TX) at À20°C until processing. Tissues were allowed to incubate in RNAlater for a minimum of 24 h. Approximately, 30 mg of tissue was disrupted by homogenization using a rotor/stator homogenizer and total RNA was isolated using the Qiagen RNeasy mini kit (Qiagen, Inc., Valencia, CA) as per the manufacturer's protocols.
Reverse transcription. High quality RNA with an A260/A280 ratio of at least 1.8 was subjected to RT-PCR. A total of 20 lg RNA was mixed with 4 ll of 10mM deoxy-nucleotide triphosphates, 12 ll of 100 ng/ll random primers (Invitrogen, Inc., Carlsbad, CA) and incubated at 65°C for 5 min followed by immediate incubation on ice for 2 min. Following this incubation, 16 ll of 53 first strand buffer, 8 ll of 0.1M dithiotreitol, 0.66 ll of RNaseOUT (40 U/ll), 4 ll of Superscript II reverse transcriptase (Invitrogen, Inc.), and 3.34 ll of H 2 O were added. The samples were incubated at 25°C for 10 min then 42°C for 50 min followed by a final incubation of 72°C for 15 min. Synthesized cDNA was then stored at À80°C until use.
amplicon from the designed primer set. The melt-curve consisted of 2 min of denaturation at 95°C followed by a ramp down to 55°C and then incremental increases of 0.5°C every 15 s for 80 cycles. Primers that failed to produce a single sharp peak on the melt curve were discarded and redesigned under more stringent conditions. Changes in relative gene expression were calculated using the comparative threshold cycle (Ct) method as described in User Bulletin #2 for the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA). Data is presented as the fold change, of gene downregulation (À2^(DDCt)) or gene upregulation (2^(ÀDDCt)). There was no difference in the 18S ribosomal RNA average Ct value between control and treated animals, data not shown.
Histological preparation. Viable pups selected for histological assessment, GD20 or PND7, were euthanized via a sodium pentobarbital overdose, ip. The trachea was exposed and cannulated with a needle (25 gauge for GD20 and 18 gauge for PND7) attached to a fixative reservoir. Whole lungs were fixed in situ, closed chest, under 20 cm of pressure with 10% neutral buffed formalin (NBF) for at least 20 min followed by a 24-h submersion in NBF. Following fixation, tissues were paraffin embedded. Tissue sections (4 lm) were cut from the paraffin-embedded blocks and placed on glass slides (Superfrost Plus, Fisher Scientific, Pittsburgh, PA). Slides selected for morphometric analysis were hematoxylin and eosin (H&E) stained. All slide preparations were performed by the Histology Services Laboratory at the University at Buffalo.
Morphometric assessment. H&E-stained images were captured with a Nikon Eclipse E400 microscope using SPOT software v3.4.5 for Windows (Diagnostic Instruments, Inc., Sterling Heights, MI). Prior to image capture, the microscope was adjusted for Köhler illumination to ensure maximum brightness with minimum glare and the SPOT software was white-balanced. Captured images were saved as TIFF files with a calculated area of 259,911 lm 2 (588 by 441 lm). For unbiased morphometric analysis, six images were randomly collected from five nonconsecutive tissue sections (separated by 4 lm) from four randomly selected animals in each treatment group resulting in 120 images collected per treatment (Balasubramaniam et al., 2005 (Balasubramaniam et al., , 2006 . The total magnification of each image was 3200. Images were inspected and excluded from further analysis if major blood vessels or bronchioles were present in the field of view. Additionally, images were excluded if the field of view was not completely filled with tissue. The remaining images were processed using a custom morphometric plug-in (Balasubramaniam et al., 2005 (Balasubramaniam et al., , 2006 written for the java based ImageJ v1.37 program (Abramoff et al., 2004) . The plug-in requires the user to first input the calibration scale (lm per pixel) and then navigate to the saved file directory containing all images. The images are first converted to an RBG (red, blue, and green) stack having 8-bits (256 gray levels) in each of the red, blue and green stacks. The green stack, which typically has the highest contrast level, is used for the remaining processing. The image is then transformed to a pure back (tissue) and white (airspace) image followed by pixel counting to generate the area of the airspace and tissue and determination of septal width. Image processing continues automatically with results saved to a TXT file.
Immunohistochemistry. Paraffin-embedded tissues were deparaffinized and rehydrated by being passed through solutions of Shandon xylene substitute (Fisher Scientific, Pittsburgh, PA), 100% ethanol, 95% ethanol, 70% ethanol, 35% ethanol, and H 2 O washes (Harrigan et al., 2006) . For immunohistochemical localization of Ahr (mouse monoclonal, Affinity BioReagents, Golden, CO), Arnt (mouse monoclonal H1beta234, Novus Biologicals, Littleton, CO) and Cyp1b1 proteins, after rehydration the slides were transferred into a slide holder containing sodium citrate buffer and heated in a steamer (Black & Decker Flavor Scenter Steamer Plus, Black & Decker, Shelton, CT) for 15 min to expose the antigenic sites (Shi et al., 2001 (Shi et al., , 2007 . Slides were washed with phosphate-buffered saline (PBS) and nonspecific binding was blocked with 1% bovine serum albumin (BSA) in PBS followed by 5% goat serum/PBS solution (Signet Laboratories/Covance, Inc. Princeton, NJ). Negative control Universal Positive Control (UPC) antibody or Ahr (1:500 1% BSA/PBS), Arnt (1:500 1% BSA/PBS), or Cyp1b1 (165-4, 1.5 lg/ml) was applied and incubated overnight at 4°C. The preparation and characterization of the Cyp1b1 antibody has been previously described (Walker et al., 1999) .
Visualization of the antibody was performed using an alkaline phosphatase labeled ultra streptavidin detection system with the provided multispecies rabbit and mouse immunoglobulin solution (Signet Laboratories/Covance, Inc. Princeton, NJ) utilizing fast red as the chromagen substrate. Following the fast red chromagen reaction, the slides were washed with H 2 O, counterstained briefly with Mayer's hematoxylin (Poly Scientific, Bay Shore, NY) and cover slipped using Permount histological mounting medium (Fisher Scientific, Pittsburgh, PA).
Image capture and color balancing of IHC images. Images were captured as previously mentioned, and saved as TIFF files. Color balancing of the histology images was performed as described earlier (McNamara, 2005) . Briefly, specimen images and a corresponding background image of the same magnification were imported into Adobe Photoshop CS2 v9.0.2 (Adobe Systems, Inc., San Jose, CA) supplemented with the Fovea Pro v4.0.1 image processing filter set (Reindeer Graphics, Inc., Asheville, NC). The background image was loaded into the Fovea Pro memory and the specimen image was processed using ''divide by'' in the general math command with a constant value of 0.004. This is a quantitative method to correct image intensity, contrast, and shading in which each pixel in the image is divided by the corresponding background image and then multiplied by a constant value (1/250 or 0.004). All images were processed using the same constant value. After color balancing, images were sharpened using the unsharp mask function within Adobe Photoshop CS2. This procedure does not allow for image quantification but merely optimizes the image for visualization and publication.
Assessment of respiratory mechanics. PND7 animals were utilized to obtain an assessment of respiratory mechanics, including PV curves. Anesthetized and euthanized neonates were placed supine with the anterior neck dissected and a tracheotomy performed with an 18 ga needle. Pups were mechanically ventilated on room air using the flexiVent computer driven small animal ventilator (SCIREQ, Montreal, Canada). Ventilation parameters were set at 150 breaths per minute, tidal volume of 10 ml/kg scaled to 14 g body weight and a maximum inflation pressure of 30 cmH 2 O (Cameron et al., 2000; Colman and Miller, 2002; Simakajornboon et al., 2004) . Following a few breaths, volume-driven static PV curves were obtained closed chest via a stepwise inflation/deflation cycle. Each individual animal's static PV curve was visually assessed prior to analysis. Curves were excluded if they showed obvious signs of air leakage. Regression analysis using Sigma Plot 10.0 (Systat Software, Inc., Port Richmond, CA) was used to fit the deflation portion of each PV curve to an exponential rise model (Equation. 1), also known as the Salazar Knowles equation (Salazar and Knowles, 1964) . In this equation, ''y'' is lung volume (V), ''P'' is pressure, ''A'' is the predicted volume of the lung at P(N), and ''B'' is the decrease in volume below ''A'' at P(0). The constant ''k'' reflects the rate at which the PV curve changes slope and indicates the shape of the curve (Colebatch et al., 1979a, b) . The coefficient of determination (R 2 ) was greater than 0.99 for the PV curves for each animal. For graphical representation, each individual PV curve was averaged and plotted.
Statistical analysis. All statistical analysis was performed using SPSS statistical software (SPSS, Inc., Chicago, IL). Parametric data was analyzed through the use of the ANOVA followed by the Tukey post hoc test to determine significant differences between groups. In all cases, results were considered statistically significant when p < 0.05.
RESULTS

Effects of Gestational Exposure to TCDD on Fetal and Neonatal Viability
The uterus was carefully dissected from the pregnant dams and assessed to determine the number of implantation sites, viable pups, embryo resorptions and LFDs (Table 2) . On GD20, fetal viability was significantly decreased in both treatment groups (1.5 or 6 lg/kg TCDD), predominately a result of LFDs (2.2 and 4.0 per litter, respectively). A statistically significant increase in the number of resorptions was noted in the 6 lg/kg TCDD exposure group at this time point. The resultant mortality rate on GD20 was 23.63 and 40.04% in the 1.5 and 6 lg/kg TCDD dose groups, respectively. Pup viability was dramatically decreased on PND7 in both TCDD treatment groups. The mortality rate was 42.59 and 100.00% in the 1.5 and 6 lg/kg TCDD dose groups, respectively. In the 6 lg/kg TCDD dose group, all pups died within 8 h of birth.
Effects of Gestational Exposure to TCDD on Fetal and Neonatal Lung Weight
To assess grossly the toxic effects of TCDD on the developing lung, we characterized several parameters of development (Table 3) . Only viable pups were used in the Note. Values present the mean (SD). The litter is considered the experimental unit for statistical analysis. N.D., not determined, there were no surviving pups in this dose group. *p < 0.05 relative to the respective control group. TCDD ALTERS LUNG DEVELOPMENT IN THE HOLTZMAN RAT 501 assessment. The litter is considered the experimental unit for analysis. On GD20, a significant decrease in body weight was observed in the 6 lg/kg TCDD dose group. Fetal wet lung weight was unaltered in the 1.5 lg/kg TCDD group, but was significantly decreased in the 6 lg/kg TCDD dose group. A similar response was observed when dry lung weight was measured. Normalized wet lung-to-body weight ratio displayed a trend of being decreased by TCDD treatment with statistical significance in the 6 lg/kg TCDD group. The normalized dry lung-to-body weight ratio was significantly decreased in both treatment groups. Evidence of pulmonary edema did not exist in either of the TCDD exposure groups indicated by similar wet lung-to-dry lung weight ratios.
On PND7, neonatal body weight, wet lung weight, and dry lung weight were not significantly different between TCDDexposed animals (1.5 lg/kg) and controls. However, both the normalized wet lung-to-body weight ratio and dry lung-to-body weight ratio were significantly decreased by TCDD exposure. There was no evidence of pulmonary edema in the TCDDexposed group.
Effects of Gestational Exposure to TCDD on Fetal and
Neonatal Gene Expression Real-time PCR was used to assess changes in expression of genes related to the Ahr-signaling pathway and markers of different cell types in the lung (Tables 4 and 5 ). Data are presented as the fold change of treated rats relative to control and a ± 2-fold change was considered to be potentially biologically relevant. The expression of Ahr and Arnt were unaltered by TCDD treatment in fetal or neonatal lungs on GD20 and PND7. A marked upregulation of Ahrr was observed on GD20 of 16.2-or 63.8-fold was observed in the fetal lung following exposure to 1.5 or 6 lg/kg TCDD, respectively. A smaller 3.95-fold upregulation of Ahrr was also seen on PND7 in the neonatal lung (1.5 lg/kg TCDD dose group).
Dioxin responsive genes Cyp1a1 and Cyp1b1 were examined to test the responsiveness of the Ahr-signaling pathway. Cyp1a1 was upregulated on GD20 in both the 1.5 and 6 lg/kg TCDD dose groups in fetal lungs, 163-and 211-fold, respectively. Cyp1a1 was also induced 57.2-fold on PND7 in the TCDD-exposed group. Cyp1b1 was upregulated 53.4-and 241.3-fold (1.5 or 6 lg/kg TCDD, respectively) in the fetal lung on GD20. On PND7, Cyp1b1 was upregulated 31.7-fold in the lung.
To determine if gestational exposure to TCDD had any effects on major cell populations of the lung, genes representative of markers for the nonciliated bronchiolar epithelial Clara cells (Scgb1a1and Muc1), alveolar type I cells (Aqp5 and Pdpn) and alveolar type II cells (Sftpa1, Sftpb, Sftpc, and Sftpd) were examined (Bourbon, 1999) . On GD20 and PND7, the expression of the Clara cell markers was not affected. Mixed results were observed for the markers of alveolar type I cells. Pdpn exhibited a 1.99-fold increase in the 1.5 lg/kg TCDD dose group but was unaltered in the 6 lg/kg TCDD dose group on GD20. Conversely, Aqp5 exhibited a 3.09-fold decrease in the 6 lg/kg TCDD dose group but was unaltered in the 1.5 lg/kg TCDD dose group. No changes in these genes were observed on PND7. The only alveolar type II Note. Values represent the average fold change (standard error of the mean) in expression in treated rats relative to controls. Real-time PCR was conducted on isolated RNA from four to six fetuses per treatment group. N.D., not determined, there were no surviving pups in this dose group. *p < 0.05 relative to the count threshold (Ct) of the control group. marker gene that was changed by TCDD exposure on GD20 was Sftpd whereas the only gene that was altered by TCDD exposure on PND7 was Sftpb. However, it is interesting to note a consistent trend with the upregulation of alveolar type II markers at both time points with all four surfactant genes increased at least 1.6-fold at PND7.
IHC Localization of Ahr, Arnt, and Cyp1b1 in Fetal and
Neonatal Lung Tissue
With real-time PCR evidence that the developing lung expresses mRNA for Ahr, Arnt, and Cyp1b1, we sought to identify the locations of these proteins via IHC. As a control, tissue sections were incubated with mouse UPC antibody which produced no positive staining (data not shown). In all images, the calibration bar is 100 lm. On GD20, Ahr was located throughout the lung epithelium and bronchiolar epithelium in both control (Fig. 1A) and TCDD treated animals ( Figs. 1D and 1G) . Ahr was not present in any smooth muscle surrounding the bronchioles. Arnt displayed a similar localization pattern on GD20 as Ahr with a majority of staining occurring in the bronchiolar epithelium, with more diffuse staining in lung epithelium in control (Fig. 1B) and treated animals (Figs. 1E and 1H ). Like Ahr, Arnt was not identified in the smooth muscle of the bronchioles. Cyp1b1 was diffusely located in the lung epithelium and bronchiolar epithelium in control animals ( Fig. 1C) with increased staining in the treated animals (1.5 or 6 lg/kg TCDD) in both lung epithelium and bronchiolar epithelium (Figs. 1F and 1I ). Similar to Ahr and Arnt, Cyp1b1 was not observed in the smooth muscle surrounding the bronchioles.
On PND7, Ahr was found throughout the lung epithelium and bronchiolar epithelium lining the bronchioles in both control ( Fig. 2A ) and treated animals (Fig. 2D) . Similar to what was observed on GD20, Ahr did not seem to be in the smooth muscle FIG. 1. Immunohistochemical localization of Ahr, Arnt, and Cyp1b1 in fetal rat lung on GD20 following a single maternal oral exposure to TCDD on GD10. Immunohistochemical localization of Ahr (control (A), 1.5 lg/kg TCDD (D), 6 lg/kg TCDD (G)), Arnt (control (B), 1.5 lg/kg TCDD (E), 6 lg/kg TCDD (H)), and Cyp1b1 (control (C), 1.5 lg/kg TCDD (F), 6 lg/kg TCDD (I)) utilizing Fast Red was performed on 4-lm tissue sections from gestation day 20 lung counterstained with hematoxylin. No fast red staining was observed in the negative control UPC mouse antibody samples, data not shown. All scale bars represent a length of 100 lm on 3200 images. Labeled structures include bronchiole (B), terminal bronchiole (TB), bronchiolar epithelium (arrow), and lung alveolar epithelium (arrow head). Control, tissue sections were incubated with mouse UPC antibody which produced no positive staining (data not shown). All images are representative of obtained results.
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503 lining the bronchioles. Arnt was primarily localized in the bronchiolar epithelium with only minimal staining of the lung epithelium (Figs. 2B and 2E ). Cyp1b1 was expressed in lung epithelium and bronchiolar epithelium in control animals (Fig.  2C) . A similar pattern of localization of Cyp1b1 was observed in the treated animals (Fig. 2F) . Cyp1b1 was not found in the smooth muscle lining the bronchioles. Interestingly, several cells in the 1.5 lg/kg TCDD exposure group that were stained were located at septal bifurcations and had a cuboidal appearance, indicative of alveolar type II cells, asterisk in (Fig. 2F) . Additionally, some cells of the vascular endothelium were stained positive for Cyp1b1 in this exposure group.
Morphometric Analysis of Lung Structure in Fetal and
Neonatal Animals Gestationally Exposed to TCDD Qualitative assessment of histological lung images from GD20 and PND7 animals (Fig. 3) suggests that gestational exposure to TCDD adversely affects development of proper lung architecture. On GD20, the lungs from the control animals (Fig. 3A) were in the transition period between the canalicular FIG. 2. Immunohistochemical localization of Ahr, Arnt, and Cyp1b1 in neonatal rat lung on PND7 following a single maternal oral exposure to TCDD on GD10. Immunohistochemical localization of Ahr (control (A), 1.5 lg/kg TCDD (D)), Arnt (control (B), 1.5 lg/kg TCDD (E)), and Cyp1b1 (control (C), 1.5 lg/kg TCDD (F)) utilizing Fast Red was performed on 4-lm tissue sections from PND7 lung counterstained with hematoxylin. No fast red staining was observed in the negative control UPC mouse antibody samples, data not shown. All scale bars represent a length of 100 lm on 3100 images. Labeled structures are artery (A), bronchiole (B), vein (V), bronchiolar epithelium (arrow), lung alveolar epithelium (arrow head), endothelium (E with arrow), and alveolar type II cell (* with arrow). Control, tissue sections were incubated with mouse UPC antibody which produced no positive staining (data not shown). All images are representative of obtained results. and saccular stage of development. Lungs from TCDDexposed animals appeared to be less well developed, remaining in the canalicular stage (Figs. 3B and 3C ). Control lungs from PND7 animals are in the saccular stage of development, but exhibited the start of thinning septal (lung tissue) walls indicative of the onset of alveolarization (Fig. 3D) . TCDDexposed animals appeared to have less air space and thickened septa (Fig. 3E) .
To quantify this observation, automated morphometric image analysis was performed on histological images (259,911 lm 2 ) from both time points (Table 6 ). On GD20, the amount of potential airspace area in the 6 lg/kg TCDD exposure group (85,823 lm 2 ) was significantly decreased when compared with control (108,814 lm 2 ). Although the average airspace area was lower in the 1.5 lg/kg TCDD exposure group (97,069 lm 2 ), compared with control the decrease in area did not reach statistical significance. A statistically significant reciprocal increase in septal area was observed in the 6 lg/kg TCDD-exposed group (174,088 lm 2 ) on GD20 when compared with control (151,097 lm 2 ). The air-septal ratio was significantly decreased in both the 1.5 and 6 lg/kg TCDD exposure groups (0.55 and 0.58, respectively) at GD20 when compared with control (0.70). Average septal width was also significantly increased in a dose dependent manner in the 1.5 and 6 lg/kg TCDD exposure groups (33.3 lm and 56.9 lm, respectively) at GD20. When compared with control (25.0 lm), septal width in the 6 lg/kg TCDD group was twofold greater (56.9 lm).
Similar to the observations on GD20, PND7 airspace area was significantly decreased by TCDD (1.5 lg/kg) when compared with control (177,434 lm 2 and 182,420 lm 2 , respectively). Conversely, septal area was significantly increased in TCDD-exposed animals when compared with controls (82,477 lm 2 and 77,409 lm 2 , respectively). There was no statistical difference in the air-septal ratio between the control and treated animals on PND7. Average septal width was significantly increased in the 1.5 lg/kg TCDD exposure group (14.8 lm) relative to the control group (11.5 lm).
Analysis of Respiratory Mechanics in PND7 Animals
Gestationally Exposed to TCDD Utilizing the SCIREQ computer driven small animal ventilator, volume-driven static PV curves were generated for PND7 animals. Each point along the PV curve represents the average of a total of 14 control rats from three litters and or 27 TCDD (1.5 lg/kg) treated rats from four litters. The control PV curve is qualitatively different than the treated PV curve (Fig. 4) . From the start of the static PV curve, TCDD- exposed   FIG. 3 . H&E-stained lung tissue sections of GD20 and PND7 animals following a single maternal oral exposure to TCDD on GD10. Representative images of H&E-stained histological sections of fetal lung on GD20 (control (A), 1.5 lg/kg TCDD (B), 6 lg/kg TCDD (C)), and PND7 (control (D), 1.5 lg/kg TCDD (E)). Images are at 3200 total magnification. For visualization, images were color balanced as described in the ''Methods.'' Scale bars represent a length of 100 lm. Mathematical modeling of the deflation segment of the curves to the Salazar Knowles equation (Salazar and Knowles, 1964) was used to quantitatively assess the differences between the treated and control rats (Fig. 4 and Table 7 ). In this equation, ''y'' is lung volume (V), ''P'' is pressure, ''A'' is the predicted volume of the lung at P(N), and ''B'' is the decrease in volume below ''A'' at P(0). The constant ''k'' reflects the rate at which the PV curve changes slope and indicates the shape of the curve (Colebatch et al., 1979a, b) . As expected, no differences between the control and treated animal values for the ''A'' and ''B'' parameters of Equation 1 were observed. The ''k'' parameter, which defines the curve's shape, was significantly different in the 1.5 lg/kg TCDD group (0.1555) when compared with control (0.2050). No differences existed in the averaged area under the deflation curve (AUC) between control and treated rat lungs or in the B/A% ratio which represents the location of the curve with respect to the x-axis (pressure).
DISCUSSION
The primary purpose of this study was to characterize the effects of gestational exposure to TCDD on the developing lung. Like all mammals, lung development in the rat proceeds through five anatomically distinct stages; embryonic (< GD13), pseudoglandular (GD13-18.5), canalicular (GD18.5-20), saccular (GD20-22), and alveolarization (PND4-28) (Pinkerton and Joad, 2000) . During the embryonic stage, epithelial, and mesenchymal tissues begin to interact, forming the buds that eventually develop into the lungs. The pseudoglandular stage is characterized by the developing lungs taking on the appearance of a gland-like structure. This stage is the most critical for the formation of all conducting airways. During this period, the airway tubular structures are lined with tall columnar epithelium, whereas the more distal structures are lined with cuboidal epithelium. The canalicular stage is when differentiation of the pulmonary epithelium occurs, resulting in the formation of the future air-blood tissue barrier. Surfactant synthesis and the canalization of the lung parenchyma by capillaries begin. The future gas exchange regions can be easily distinguished from the future conducting airways of the lungs. The saccular stage is identified when the most peripheral airways form widened airspaces, termed saccules. These saccules widen and lengthen the airspace in large measure by the addition of new generations, significantly expanding the future gas exchange region. The final stage of alveolarization occurs postnatally. During this period, the walls of the saccules thin and continue to exhibit complex branching, resulting in the formation of alveoli. The experimental design in this study utilized a single oral exposure of pregnant Holtzman rats to TCDD on GD10. This results in the developing conceptus being both gestationally and postnatally (lactationally) exposed to TCDD during all stages of lung development.
Work by Hurst et al. (1998 Hurst et al. ( , 2000 has shown that the disposition of TCDD into the developing conceptus from placental transfer from the dam increases over time. In this study, timed pregnant long evans rats administered a single oral dose of [ 3 H] TCDD (1.15 lg/kg) on GD8 had detectible and increasing levels of TCDD in the embryonic/fetal tissues on GD9, GD16 and GD20. On GD9, 0.01% of the administered maternal dose reached the embryonic compartment, whereas on GD20, TCDD levels increased to 0.71% of the maternal dose (Hurst et al. 1998 (Hurst et al. , 2000 .
Our results shown that on GD20 and PND7, TCDD-exposed animals exhibited a significant decrease in the normalized wet   FIG. 4 . Volume-driven static PV curves generated in PND7 rat lungs following a single maternal oral exposure to TCDD on GD10. Static volumedriven PV curves were generated from a step-wise breath in which changes in pressure and volume were monitored in PND7 animals from dams exposed to 1.5 lg/kg TCDD on GD10 and in age matched controls. Each point along the PV curve represents the average of a total of 14 control rats from three litters (solid circle) or 27 TCDD treated rats from four litters (open square). Note. Values present the mean (SD) of the average from 14 control rats from three litters and 27 treated rats from four litters. (A) is the predicted volume of the lung at pressure (P) P(N), (B) is the decrease in volume below (A) at P(0), (k) reflects the rate at which the PV curve changes slope and indicates the shape of the curve, (B/A%) represents the location of the curve with respect to the x-axis (pressure), and (AUC) is calculated for the deflation limb. *p < 0.05 compared with control.
lung-to-body weight ratio and dry lung-to-body weight ratio (Table 3 ). The decrease in normalized lung weight provides evidence that gestational exposure to TCDD induces pulmonary hypoplasia. Concurrently, the decrease in normalized lung weight is not associated with pulmonary edema, indicated by the consistent wet lung-to-dry lung weight ratio at both time points.
Pulmonary hypoplasia is defined as incomplete development of the lung resulting in the failure to reach adult size and weight (Laudy and Wladimiroff, 2000) . This defect in development can be the result of a several factors such as a decrease in the number of lung cells, airways and/or alveoli. There are two etiologies of pulmonary hypoplasia, as a primary or secondary complication. Pulmonary hypoplasia as a primary complication is rare. Infants with this defect are believed to have suffered from decreased fetal breathing movements in utero (Laudy and Wladimiroff, 2000) . More commonly, pulmonary hypoplasia is a secondary complication to congenital anomalies, pregnancy complications or chemical exposure. For example, intrauterine growth restriction has been shown to limit the amount of oxygen and nutrients available for the fetal lung resulting in growth retardation and post natal respiratory defects (Curle and Adamson, 1978; Harding et al., 2000 Harding et al., , 2004 Lipsett et al., 2006; Wignarajah et al., 2002) . Mothers on pharmacotherapy regiments with the angiotensin II receptor antagonists losartan and valsartan have been shown to have newborns with pulmonary hypoplasia (Bos-Thompson et al., 2005) . Likewise, in rats, exposure to betamethasone during the last week of gestation induces pulmonary hypoplasia (McDonald et al., 2003) . Despites these observations, the precise mechanisms leading to pulmonary hypoplasia are not completely understood.
Because gestational exposure to TCDD induces pulmonary hypoplasia, we sought to determine if the Ahr-signaling pathway is present and responsive in the developing lung through the use of real-time PCR quantification of mRNA for Ahr, Ahrr, Arnt, Cyp1a1, and Cyp1b1 (Tables 4 and 5 ) and IHC localization of Ahr, Arnt, and Cyp1b1 (Figs. 2 and 3) . Real-time PCR confirmed the presence of Ahr and Arnt within the developing lung on GD20 and PND7. These results are consistent with findings of Jain et al. in which in situ hybridization was used to localize Ahr and Arnt in the developing mouse on GD13.5 (Jain et al., 1998) . Jain et al. (1998) also observed that on GD9.5 the primitive foregut did not exhibit any Ahr signal, which could suggest that Ahr signaling may have a temporal component potentially based on developmental age.
One notable observation with regard to Ahr signaling was the induction of Ahrr (Tables 4 and 5 ). Compared with Ahr and Arnt, less is known about the role of Ahrr in the Ahr-signaling pathway. Ahrr contains high sequence homology to Ahr in the bHLH and PAS-A regions, but lacks a ligand binding site (Mimura et al., 1999) . Work by Bershausen et al. and Tsuchiya et al. has demonstrated that Ahrr mRNA is constitutively expressed in multiple tissues, Ahr signaling is involved in the regulation of constitutive expression of Ahrr and that there is not a strong relationship between Ahrr expression and responsiveness of Cyp1a1 induction by Ahr ligands (Bernshausen et al., 2006; Tsuchiya et al., 2003) . It is thought that Ahrr competes with Ahr for Arnt binding, resulting in Ahrr-Arnt complexes binding to DREs which effectively inhibits Ahr-mediated gene expression (Mimura et al., 1999) , although other mechanisms not fully understood have also been implicated (Evans et al., 2008) . The marked induction of Ahrr by TCDD in the developing lung is a noteworthy observation which supports the need for further characterization of the biological and physiological purpose of Ahrr-mediated inhibition.
We also confirmed by real-time PCR that the Ahr pathway is responsive to ligand (TCDD) binding and leads to changes in gene transcription demonstrated by the induction of Cyp1a1, Cyp1b1, and Ahrr mRNA (Tables 4 and 5 ). Both cytochrome P450s examined were induced in the lung on GD20 and PND7 by TCDD. These results are consistent with the findings that Cyp1a1 and Cyp1b1 mRNA are inducible in fetal (Choudhary et al., 2003 (Choudhary et al., , 2005 Xu and Miller, 2004; Xu et al., 2005) and neonatal lung tissue (Gamieldien and Maritz, 2004) . Our results also demonstrate time specific differences in the magnitude of cytochrome P450 induction. The magnitude of Cyp1a1 and Cyp1b1 mRNA induction in the lung were greater on GD20 than PND7.
With our findings that mRNA for Ahr, Arnt, and Cyp1b1 are present within the developing lung, we sought to determine the cellular localization of these proteins. IHC confirmed the presence of Ahr and Arnt within the developing lung and localized the proteins to both lung alveolar epithelium and bronchiolar epithelium on GD20 and PND7 ( Figs. 1 and 2 ). These findings are consistent with the results that epithelial cell lines representative of alveolar type II cells (A594 and HPL1A) and bronchial epithelial cells (BEAS-2B) are responsive to TCDD (Lin et al., 2004; Martinez et al., 2002) . Cyp1b1 displayed a similar localized staining pattern as Ahr and Arnt at both time points with slight staining of the lung epithelium and intense staining of the bronchial epithelial cells. Interestingly, on PND7 in the 1.5 lg/kg TCDD exposure group, vascular endothelium and a few presumable alveolar type II cells stained for Cyp1b1 (Fig. 2F) . Our results are consistent with other studies in which the Clara cells that line the bronchioles have been shown to have TCDD inducible Cyp1a1 and Cyp1b1 (Chang et al., 2006) . Further confirmation is given by in situ hybridization and IHC studies which have localized Cyp1a1 to alveolar epithelium (type I and type II cells), bronchiolar epithelium and vascular endothelium (Saarikoski et al., 1998) .
Because activation of the Ahr-signaling pathway leads to a variety of changes in global gene transcription, of which some are related to cellular differentiation and proliferation (Tijet et al., 2006) , we examined the effect of our treatment paradigm on genetic markers of main lung cell populations. Expression profiles for the markers of the nonciliated bronchiolar Clara cells (Scgb1a1 and Muc1), alveolar type I cells (Aqp5 and Pdpn) and alveolar type II cells (Sftpa1, Sftpb, Sftpc, Sftpd) were examined by real-time PCR (Tables 4 and 5 ).
TCDD ALTERS LUNG DEVELOPMENT IN THE HOLTZMAN RAT
Generally, no correlations between changes in gene expression and exposure to TCDD at the two time points examined were observed. Two exceptions to these results were the slight induction of Sftpd at these two time points and Sftpb induction on PND7. In addition, mRNA for all four surfactant proteins were upregulated > 1.5-fold at 9 of 12 of the doses and times investigated. This may be biologically meaningful because analysis of whole lung tissue dilutes attempts to quantify changes that may be occurring in specific cell types, such as alveolar type II cells. However, PCR results from the whole lung do not answer the question of whether TCDD altered cellspecific gene expression and/or cell number. Future work is necessary to examine the effect of TCDD on the number and function of individual cell populations within the lung.
To correlate these changes with alterations in lung structure and respiratory function, studies were undertaken to quantitatively assess the morphology of the developing lung and functional respiratory mechanics. Qualitative assessment of H&E-stained tissue sections on GD20 and PND7 suggests that lung structure is altered in treated animals when compared with controls (Fig. 3 ). It appears treated animals have less airspace and wider septal tissue. Morphometric analysis was used to calculate airspace/septal area, airspace-septal ratio and septal width in control and treated animals on GD20 and PND7 using established morphometric methodology (Askenazi and Perlman, 1979; Bolender et al., 1993; Cooney and Thurlbeck, 1982; Emery and Mithal, 1960; Pua et al., 2005) . Supporting our initial qualitative observations, gestational exposure to TCDD resulted in statistically significant decreases in airspace area with reciprocal increases in septal area and septal width in the 6 lg/ kg TCDD exposure group on GD20 and in the 1.5 lg/kg TCDD exposure group on PND7 (Table 6 ). Lungs from control animals displayed normal developmental progression with formation of sac-like airspace structures. Compared with controls, TCDDexposed animals had less airspace area and thickened septa. These results suggest that lung development does not proceed in a normal fashion in TCDD-exposed animals.
In the normal progression of lung development, the lung simultaneously grows in size, whereas the septa saccules transform into alveolar walls through a thinning process associated with increased branching into the functional airexchange chambers. TCDD exposure results in a defect in normal septation and initial alveolarization leading to altered three-dimensional growth, characteristic of a developmental delay and manifested as pulmonary hypoplasia.
With evidence that lung architecture on GD20 and PND7 is altered with gestational exposure to TCDD, we sought to investigate whether this alteration would adversely affect functional respiratory mechanics. Using the SCIREQ computer driven small animal ventilator and mathematic data fitting, we confirmed that respiratory mechanics are altered in TCDDexposed animals. Initial attempts to generate data at the GD20 time point were unsuccessful due to several technical limitations. First, the lungs of GD20 animals are filled with fluid. Removing the pups from the uterus did not stimulate breathing because the dams were euthanized via an ip overdose of sodium pentobarbital which can cross the placenta and effect the developing conceptus (Mork et al., 1970) . Second, performing the tracheotomy on these animals was technically challenging. The tracheal tissue was extremely friable and small; tracheal width is approximately 1.5 mm. Finally, GD20 pups that were successfully attached to the ventilator quickly had lung rupture once the ventilator perturbation started, likely due to volume controlled inspiration of forced air into the fluid filled cavity effectively creating a hydraulic system that overpressurized the lung. Thus all measurements of respiratory mechanics are limited to viable animals at 7 days post partum.
Generation of static PV curves for PND7 animals was accomplished. Once attached to the computer driven ventilator, each euthanized animal was administered a few breaths prior to being subjected to a volume-driven static PV curve perturbation. Initial qualitative assessment of the static PV curves revealed the treated animals (1.5 lg/kg TCDD) had different respiratory mechanics than controls (Fig. 4) . The overall general shapes of our PV curves are similar to previous studies examining respiratory mechanics in neonatal rats on PND10 (Broussard et al., 2006) . From the start of the static PV curve, TCDD-exposed animals require more pressure to achieve comparable changes in lung volume compared with controls.
Mathematical data fitting is crucial for interpretation of PV curves, as it can aid in understanding pulmonary disease progression and ensure proper clinical settings of mechanically ventilated patients (Albaiceta et al., 2007; Harris, 2005; Harris et al., 2000; Jonson, 2005; Lichtwarck-Aschoff et al., 2000; Martin-Lefevre et al., 2001; Venegas et al., 1998) . The deflation limb of the static PV curves was fit to the exponential equation defined by Salazar and Knowles, Equation 1 (Salazar and Knowles, 1964) . The data generated from the curve fitting (Table 7) , provides quantitative evidence that respiratory function in treated animals is different than controls. As expected, there were no differences in the ''A'' or ''B'' parameters. The ''k'' parameter (0.1555) in the treated group when compared with control (0.2050) was significantly decreased. The ''k'' parameter of Equation 1 is believed to change from both fibrosis and emphysema (Colebatch et al., 1979a, b) and is proposed to be superior to the compliance estimate as an overall measure of lung elastic properties independent of lung size (Bogaard et al., 1995; Knudson and Kaltenborn, 1981) . The decrease in the ''k'' value suggests that lung of PND7 animals gestationally exposed to TCDD has increased elastic recoil. This observation is supported by our finding that treated animals require more pulmonary pressure to achieve similar changes in lung volume when compared with control animals (Fig. 4) .
Together, these results show that there was a dose-related difference in lung development, structure and function at GD20 which may be a contributing factor to the increased rates of mortality observed (Table 2) . These results are supported by the marked delay in development in the high dose TCDD group (6 lg/kg) at GD20 which could contribute directly to the early postnatal lethality at this level of exposure; there were no surviving pups on PND7. It is also note worthy that increased postnatal lethality also occurs in the low dose (1.5 lg/kg) group, but the pups that survived had marked changes in lung structure and function.
In summary, the results from this study confirm that the developing lung is a target for TCDD and that the Ahr-signaling pathway (Ahr and Arnt) is present within the developing lung on GD20 and PND7 at both the mRNA and protein level. Through the use of IHC, these two proteins were generally localized in the lung alveolar epithelium and in the bronchiolar epithelium and not in smooth muscle surrounding the bronchioles. The Ahrsignaling pathway in the developing lung is responsive to TCDD exposure demonstrated by the induction of mRNA for Cyp1a1 and Cyp1b1. The localization pattern of Cyp1b1 was similar to that of Ahr and Arnt. The marked upregulation of Ahrr with TCDD exposure in the developing lung is a novel finding warranting further investigation. Despite gestational exposure to TCDD inducing lung hypoplasia, there was no clear evidence that this was related to alterations in the various lung cell populations, with the possible exception of alveolar type II cells, as assessed by changes in mRNA levels for the surfactant proteins. Quantitative morphometric analysis demonstrated that lung development is delayed on GD20 and PND7 in animals gestationally exposed to TCDD on GD10. At both time points, the delay was characterized by decreases in airspace and reciprocal increases in septal tissue area and septal width. These changes in lung morphology correlated with differences in static PV curves. On PND7, at all points along the PV curve, TCDD-exposed animals required more pressure to achieve comparable changes in lung volume compared with controls. Mathematical modeling of the deflation limb of the static PV curve demonstrated that although estimated total lung capacity is similar between the TCDD treated and control groups, the shape factor of the curves, and an indicator of elastance, is significantly different. Lung development is critically dependent on the precise temporal and spatial action of a variety of transcription factors and other morphoregulatory molecules. Although the role of the Ahr-signaling pathway has never been investigated in lung development, these data suggest that Ahr hyperactivation as a result of gestational exposure to TCDD during all stages of lung development adversely affects the process. Future studies at lower doses will be needed to assess the impact of TCDD at various stages of lung development to address mechanistic questions and the important issue of whether the lung is an early, sensitive, primary target of the developmental toxicity of TCDD. 
